NCT05554744 2022-09-27
EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors
Guangxi Medical University
Phase NA Unknown
Clinical Trials
9 trialsNCT02294006 2021-09-09
MetNET1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT03435770 2018-02-20
Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms
Singapore General Hospital
Phase NA Unknown
NCT03417843 2018-02-13
yes
HaEmek Medical Center, Israel
Phase NA Unknown
NCT01563133 2017-08-29
CONTACT
Mauna Kea Technologies
Phase NA Unknown
NCT03204019 2017-06-29
A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor
ChineseAMS
Phase 2 Unknown
NCT02759718 2016-05-03
CgA
Asan Medical Center
Phase 4 Unknown
NCT02455596 2016-01-05
Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 2 Unknown
NCT02038738 2014-01-17
68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors
Ochsner Health System
Phase 1/2 Unknown